To this end, we interrogated The Cancer Genome Atlas low-grade glioma-GBM (LGG-GBM) dataset (n = 607) and found that high CD44 expression is enriched in GBM [World Health Organization (WHO) grade 4] compared with LGGs (WHO grades 2 and 3). Here, CD44 is linked to glioblastoma.